EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

EQRx, a pharmaceutical company focused on providing innovative medicines for conditions like cancer and immune-inflammatory diseases, announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 4:30 p.m. PST / 7:30 p.m. EST. The event will include a live and archived webcast accessible via the company’s website. Since its launch in January 2020, EQRx has aimed to enhance access to medicines through advanced science and strategic collaborations.

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 4:30 p.m. PST / 7:30 p.m. EST.

A live and archived webcast of the presentation will be available by visiting the News & Events section of EQRx’s website, and selecting Events & Presentations, at investors.eqrx.com.

About EQRx
EQRx is a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions. Launched in January 2020, EQRx is leveraging cutting-edge science, technology and strategic partnerships with stakeholders from across the healthcare system toward the goal of increasing access for patients around the world. To learn more, visit www.eqrx.com and follow us on social media: Twitter: @EQRx_US, LinkedIn, Instagram: @eqrxinc.

EQRx™ and Remaking Medicine™ are trademarks of EQRx.

EQRx Contacts:

Media:
Dan Budwick
1AB
dan@1abmedia.com

Investors:
investors@eqrx.com

 

FAQ

When will EQRx present at the J.P. Morgan Healthcare Conference?

EQRx will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 4:30 p.m. PST / 7:30 p.m. EST.

How can I watch the EQRx presentation at the conference?

You can watch the EQRx presentation live or access the archived version by visiting the News & Events section on the EQRx website.

What is EQRx's mission?

EQRx is committed to developing and expanding access to innovative medicines for prevalent diseases, including cancer and immune-inflammatory conditions.

When was EQRx founded?

EQRx was founded in January 2020.

What diseases does EQRx focus on?

EQRx focuses on diseases such as cancer and immune-inflammatory conditions.